📊 DHCNL Key Takeaways
Investment Thesis
Diversified Healthcare Trust is experiencing severe operational distress with substantial net losses, negative free cash flow of -1.2B, and deteriorating cash generation despite modest revenue growth. The company's negative net margin of -18.6%, minimal interest coverage of 0.2x, and operating cash flow deficit indicate fundamental business challenges that threaten financial viability and debt service capacity.
DHCNL Strengths
- Modest revenue growth of 2.8% YoY demonstrates some market demand
- Positive operating income of 41.7M shows potential profitability at operational level
- Reasonable asset base of 4.4B provides collateral and business foundation
DHCNL Risks
- Severe net losses of -285.9M with -18.6% net margin indicate structural unprofitability
- Negative free cash flow of -1.2B and negative operating cash flow of -19.6M threaten debt service and sustainability
- Dangerously low interest coverage ratio of 0.2x with 2.4B long-term debt creates acute default risk
- High leverage with 1.47x debt-to-equity ratio combined with negative returns (ROE -17.2%, ROA -6.6%)
- Capital expenditure of 1.2B against negative operating cash flow indicates unsustainable capital allocation
Key Metrics to Watch
- Operating cash flow trajectory and return to positive generation
- Interest coverage ratio improvement and debt service capability
- Path to net profitability and net margin expansion
- Free cash flow conversion and working capital management
- Debt reduction progress and leverage ratio improvement
DHCNL Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
DHCNL Profitability Ratios
DHCNL vs Default Sector
How DIVERSIFIED HEALTHCARE TRUST compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
DHCNL Balance Sheet & Liquidity
DHCNL 5-Year Financial Trend
5-Year Trend Summary: DIVERSIFIED HEALTHCARE TRUST's revenue has remained relatively flat over the 5-year period, with a 6% decline. The most recent EPS of $-1.23 indicates the company is currently unprofitable.
DHCNL Growth Metrics (YoY)
DHCNL Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $373.6M | -$9.0M | $-0.41 |
| Q2 2025 | $371.4M | -$9.0M | $-0.38 |
| Q1 2025 | $370.8M | -$9.0M | $-0.04 |
| Q3 2024 | $356.5M | -$52.7M | $-0.28 |
| Q2 2024 | $346.2M | -$52.7M | $-0.30 |
| Q1 2024 | $346.0M | -$52.7M | $-0.22 |
| Q3 2023 | $322.9M | $49.5M | $0.21 |
| Q2 2023 | $313.0M | -$72.6M | $-0.30 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
DHCNL Capital Allocation
DHCNL SEC Filings
Access official SEC EDGAR filings for DIVERSIFIED HEALTHCARE TRUST (CIK: 0001075415)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DHCNL
What is the AI rating for DHCNL?
DIVERSIFIED HEALTHCARE TRUST (DHCNL) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are DHCNL's key strengths?
Claude: Modest revenue growth of 2.8% YoY demonstrates some market demand. Positive operating income of 41.7M shows potential profitability at operational level.
What are the risks of investing in DHCNL?
Claude: Severe net losses of -285.9M with -18.6% net margin indicate structural unprofitability. Negative free cash flow of -1.2B and negative operating cash flow of -19.6M threaten debt service and sustainability.
What is DHCNL's revenue and growth?
DIVERSIFIED HEALTHCARE TRUST reported revenue of $1.5B.
Does DHCNL pay dividends?
DIVERSIFIED HEALTHCARE TRUST pays dividends, with $9.7M distributed to shareholders in the trailing twelve months.
Where can I find DHCNL SEC filings?
Official SEC filings for DIVERSIFIED HEALTHCARE TRUST (CIK: 0001075415) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DHCNL's EPS?
DIVERSIFIED HEALTHCARE TRUST has a diluted EPS of $-1.19.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.